Product Code: ETC13128619 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Positron Emission Tomography Market was valued at USD 2.45 Billion in 2024 and is expected to reach USD 3.9 Billion by 2031, growing at a compound annual growth rate of 6.80% during the forecast period (2025-2031).
The global Positron Emission Tomography (PET) market is experiencing steady growth driven by the increasing prevalence of chronic diseases such as cancer and neurological disorders, advancements in imaging technologies, and growing awareness about early disease detection. The market is characterized by the rising adoption of hybrid PET-CT and PET-MRI systems, as well as the development of new radiotracers for improved imaging accuracy. North America dominates the market due to high healthcare expenditure and technological advancements, while the Asia-Pacific region is expected to witness significant growth due to improving healthcare infrastructure and rising investments in medical imaging technologies. Key players in the global PET market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, among others, who are focusing on innovation and strategic collaborations to enhance their market presence.
The global Positron Emission Tomography (PET) market is experiencing significant growth driven by technological advancements, increasing prevalence of chronic diseases such as cancer, and rising demand for early and accurate diagnostic procedures. Key trends in the market include the development of hybrid PET/CT and PET/MRI systems, expanding applications in neurology and cardiology, and the growing adoption of digital PET scanners for improved image quality and reduced scan times. Opportunities in the market lie in emerging markets with increasing healthcare infrastructure investments, research and development activities focused on radiopharmaceuticals, and partnerships between healthcare providers and industry players to enhance PET imaging capabilities. Overall, the PET market is poised for continued expansion with a focus on innovation, efficiency, and improved patient outcomes.
Some challenges faced in the Global Positron Emission Tomography (PET) Market include high installation and maintenance costs associated with PET machines, limited availability of radiotracers for imaging procedures, regulatory hurdles in some regions, and competition from other advanced imaging technologies such as MRI and CT scans. Additionally, the limited reimbursement policies for PET scans in certain healthcare systems can hinder the market growth. Moreover, the need for specialized training for healthcare professionals to operate PET machines effectively adds to the challenges faced by the industry. As technology advances and research progresses, addressing these challenges will be crucial for the sustained growth and adoption of PET imaging in the global healthcare sector.
The global Positron Emission Tomography (PET) market is primarily driven by factors such as the increasing prevalence of chronic diseases like cancer and neurological disorders, growing demand for early and accurate diagnosis, advancements in imaging technologies leading to improved PET scanners, and rising investments in healthcare infrastructure. Additionally, the expanding applications of PET imaging in areas such as oncology, cardiology, and neurology, along with the rising geriatric population worldwide, are also contributing to the market growth. Moreover, the growing awareness among healthcare professionals and patients about the benefits of PET imaging for personalized medicine and treatment planning further fuels the demand for PET scanners and related services in the global market.
Government policies related to the Global Positron Emission Tomography (PET) Market vary by country but generally focus on regulatory approval, reimbursement policies, and healthcare infrastructure development. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU play a crucial role in approving PET imaging agents and devices for clinical use. Reimbursement policies, often set by government healthcare agencies, determine the level of financial support provided for PET scans, influencing patient access and market demand. Additionally, government investments in healthcare infrastructure, including PET imaging facilities and training programs for healthcare professionals, impact market growth and adoption rates. Overall, government policies in the Global PET Market aim to ensure patient safety, affordability, and access to advanced diagnostic technologies.
The Global Positron Emission Tomography (PET) Market is expected to witness significant growth in the coming years, driven by increasing prevalence of chronic diseases such as cancer and neurological disorders, as well as advancements in PET imaging technology. The market is also likely to benefit from the rising demand for early and accurate diagnosis, personalized medicine, and the expanding applications of PET imaging beyond oncology. Moreover, the growing investments in healthcare infrastructure, rising healthcare expenditure, and increasing awareness about the benefits of PET scans are anticipated to further propel market growth. However, challenges such as high cost associated with PET scans, limited reimbursement policies, and the availability of alternative imaging modalities may hinder market expansion to some extent. Overall, the Global PET Market is projected to experience steady growth in the foreseeable future.
In the global Positron Emission Tomography (PET) market, North America holds the largest market share due to the presence of advanced healthcare infrastructure, high adoption rates of PET technology, and significant investments in research and development. Europe follows closely behind, driven by increasing awareness about early disease diagnosis and treatment monitoring. Asia-Pacific is expected to witness the highest growth rate in the PET market, attributed to the rising prevalence of chronic diseases, improving healthcare facilities, and growing investments in healthcare infrastructure. In the Middle East and Africa region, the market is experiencing steady growth due to increasing government initiatives to enhance healthcare services. Latin America is also showing promising growth prospects, driven by improving healthcare access and rising disposable incomes among the population.
Global Positron Emission Tomography (PET) Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Positron Emission Tomography (PET) Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Positron Emission Tomography (PET) Market Revenues & Volume, 2021 & 2031F |
3.3 Global Positron Emission Tomography (PET) Market - Industry Life Cycle |
3.4 Global Positron Emission Tomography (PET) Market - Porter's Five Forces |
3.5 Global Positron Emission Tomography (PET) Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Positron Emission Tomography (PET) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Positron Emission Tomography (PET) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Positron Emission Tomography (PET) Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Global Positron Emission Tomography (PET) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Positron Emission Tomography (PET) Market Trends |
6 Global Positron Emission Tomography (PET) Market, 2021 - 2031 |
6.1 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Full Ring PET Scanners, 2021 - 2031 |
6.1.3 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Partial Ring PET Scanners, 2021 - 2031 |
6.2 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.2.3 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.4 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.5 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.4 Global Positron Emission Tomography (PET) Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Positron Emission Tomography (PET) Market, Overview & Analysis |
7.1 North America Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
7.2 North America Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Latin America (LATAM) Positron Emission Tomography (PET) Market, Overview & Analysis |
8.1 Latin America (LATAM) Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
9 Asia Positron Emission Tomography (PET) Market, Overview & Analysis |
9.1 Asia Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
10 Africa Positron Emission Tomography (PET) Market, Overview & Analysis |
10.1 Africa Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
11 Europe Positron Emission Tomography (PET) Market, Overview & Analysis |
11.1 Europe Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
12 Middle East Positron Emission Tomography (PET) Market, Overview & Analysis |
12.1 Middle East Positron Emission Tomography (PET) Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Positron Emission Tomography (PET) Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Positron Emission Tomography (PET) Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Positron Emission Tomography (PET) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Positron Emission Tomography (PET) Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Positron Emission Tomography (PET) Market, Revenues & Volume, By End-User, 2021 - 2031 |
13 Global Positron Emission Tomography (PET) Market Key Performance Indicators |
14 Global Positron Emission Tomography (PET) Market - Export/Import By Countries Assessment |
15 Global Positron Emission Tomography (PET) Market - Opportunity Assessment |
15.1 Global Positron Emission Tomography (PET) Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Positron Emission Tomography (PET) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Positron Emission Tomography (PET) Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Positron Emission Tomography (PET) Market Opportunity Assessment, By End-User, 2021 & 2031F |
16 Global Positron Emission Tomography (PET) Market - Competitive Landscape |
16.1 Global Positron Emission Tomography (PET) Market Revenue Share, By Companies, 2024 |
16.2 Global Positron Emission Tomography (PET) Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |